Two Hot Stocks Comparison: Intellia Therapeutics, Inc. (NASDAQ:NTLA), DPW Holdings, Inc. (NYSE:DPW)

earning reaction history, nasdaq, nyse

Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Intellia Therapeutics, Inc. (NASDAQ:NTLA) closed at $19.59 on the last trading session with an increase of 1.77%, whereas, it previously closed at $19.25. The company has a market capitalization of $1.15 Billion. The company traded shares of 669624 on the trading day while its three month average volume stands at 995.6 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) produced diluted EPS of -2.25. The EPS estimate for next year as estimated by analysts is at -2.91 while EPS for next quarter is estimated at -0.69. Earnings per Share growth for this year is reported at -6.3, while the analysts estimated the EPS growth for next year at -2.91% and Earnings growth for next 5 years stands at 30% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -50.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Intellia Therapeutics, Inc. (NASDAQ:NTLA) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands at 25.31 and Price to Book or P/B for the most recent quarter stands at 3.99. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Intellia Therapeutics, Inc. (NASDAQ:NTLA) are reported at 7.6 and 7.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands at -32.5, -40.9 and 0 respectively

The trailing twelve month Revenue of Intellia Therapeutics, Inc. (NASDAQ:NTLA) is reported at 45.6 Million with income of -109400000. The outstanding shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) are 50.49 Million. The institutional Ownership of the shares of 71.5 stands at 0.80%, this figure is decreased -0.25 in the last six months. The insider ownership for the shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) is ticked at 0.9%, the figure is plummeted -4.82% in the last six months.

Some other important financial aspects to be discussed here for Intellia Therapeutics, Inc. (NASDAQ:NTLA) is the Mean Target Price estimated by the analysts which stands at 28.65. The 52 week high of Intellia Therapeutics, Inc. (NASDAQ:NTLA) is placed at 25.56 and 52 week low is standing at 9.18.

Performance wise the shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) rose up 2.83% for the week, it also fell -12.89% for the monthly performance, while for the quarter it went down 41.75%. The shares increase 42.58% for the half year and flew up for the Year-To-Date performance. The shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) grew 16.33% for the yearly performance.

DPW Holdings, Inc. (NYSE:DPW)

DPW Holdings, Inc. (NYSE:DPW) closed at $2.91 on the last trading session with an increase of 6.2%, whereas, it previously closed at $2.74. The company has a market capitalization of $16.99 Million. The company traded shares of 3.53 Million on the trading day while its three month average volume stands at 4.59 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of DPW Holdings, Inc. (NYSE:DPW) produced diluted EPS of -16.28. The EPS estimate for next year as estimated by analysts is at 0 while EPS for next quarter is estimated at 0. Earnings per Share growth for this year is reported at 94.9, while the analysts estimated the EPS growth for next year at 0% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 21.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of DPW Holdings, Inc. (NYSE:DPW) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of DPW Holdings, Inc. (NYSE:DPW) stands at 0.67 and Price to Book or P/B for the most recent quarter stands at 5.29. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of DPW Holdings, Inc. (NYSE:DPW) are reported at 0.3 and 0.4 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for DPW Holdings, Inc. (NYSE:DPW) stands at -72.7, -266.7 and -156.2 respectively

The trailing twelve month Revenue of DPW Holdings, Inc. (NYSE:DPW) is reported at 25.2 Million with income of -31100000. The outstanding shares of DPW Holdings, Inc. (NYSE:DPW) are 6.11 Million. The institutional Ownership of the shares of 3.6 stands at 0.80%, this figure is increased 0 in the last six months. The insider ownership for the shares of DPW Holdings, Inc. (NYSE:DPW) is ticked at 19.88%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for DPW Holdings, Inc. (NYSE:DPW) is the Mean Target Price estimated by the analysts which stands at 0. The 52 week high of DPW Holdings, Inc. (NYSE:DPW) is placed at 10.68 and 52 week low is standing at 0.53.

Performance wise the shares of DPW Holdings, Inc. (NYSE:DPW) rose up 18.78% for the week, it also rise 27.07% for the monthly performance, while for the quarter it went down 164.55%. The shares increase 100.69% for the half year and flew up for the Year-To-Date performance. The shares of DPW Holdings, Inc. (NYSE:DPW) shrinked -46.27% for the yearly performance.